Nurx BBB and Consumer-Complaint Trends: An Independent Review

At a glance
- BBB rating / B to B+ (fluctuates; not BBB-accredited as of 2025)
- Primary complaint category / billing and subscription charges
- Second most common complaint / prescription or refill delays
- Founded / 2015, headquartered in San Francisco, CA
- Services covered / birth control, HRT, skin care, STI testing, PrEP, hair loss
- Prescriber model / asynchronous + synchronous telemedicine, all 50 states
- Insurance accepted / yes, plus cash-pay pricing
- LegitScript status / certified online pharmacy (verify current status at legitscript.com)
- FDA oversight / dispensing partners must comply with 21 CFR Part 1300 pharmacy standards
- State medical board complaints / reported in CA, NY, TX (see body for details)
Is Nurx a Legitimate Telehealth Service?
Nurx is a licensed telehealth platform. It works with state-licensed prescribers and pharmacy partners that must comply with federal and state pharmacy law, including DEA and FDA dispensing regulations under 21 CFR Part 1306. LegitScript, the third-party pharmacy verification body used by Google, Visa, and Mastercard, has historically listed Nurx among certified online pharmacy operators, meaning it passed LegitScript's checks for valid prescriptions, licensed pharmacists, and physical address disclosure.
What "Legitimate" Actually Means in Telehealth
Legitimacy in telehealth is not binary. A platform can be legally licensed and still generate high complaint volumes. The FDA defines a legitimate online pharmacy as one that requires a valid prescription, is licensed by the state board of pharmacy, and provides a licensed pharmacist for consultations. FDA guidance on buying medicines online lists these criteria explicitly.
Nurx meets those structural criteria. The operational problems documented in consumer complaints are separate from licensure and do not, by themselves, make the platform illegal.
How Nurx Is Structured
Nurx uses an asynchronous telemedicine model. Patients complete an intake questionnaire; a contracted clinician reviews it and, if appropriate, sends a prescription to a pharmacy partner. For birth control, this model is supported by CDC guidance: the CDC US Medical Eligibility Criteria for Contraceptive Use (US MEC) establishes evidence-based eligibility screening criteria that telehealth platforms can apply without in-person pelvic exams. Nurx's intake process is designed around US MEC categories 1 through 4.
Nurx BBB Rating and Complaint History
The Better Business Bureau is not a government regulator, but its complaint database is a useful proxy for operational patterns. As of early 2025, Nurx's BBB profile shows a rating between B and B+, with the company not holding BBB accreditation. Non-accreditation matters because accredited businesses agree to BBB's binding arbitration standards; without accreditation, resolution is voluntary.
Volume and Categories of BBB Complaints
The BBB complaint categories most associated with Nurx over the 36 months ending January 2025 are:
- Billing and collection issues. Patients report unexpected subscription charges after cancellation, difficulty obtaining refunds, and charges for consultations that did not result in a prescription.
- Delivery and fulfillment problems. Complaints describe prescriptions sent to incorrect pharmacies, shipments never received, and refill gaps lasting 2 to 4 weeks.
- Service or product quality issues. These include clinician responses perceived as generic, requests for additional labs that patients felt were unnecessary, and communication delays exceeding 72 hours.
The BBB's own published standard is that a business should respond to complaints within 14 days. Nurx's response rate on the BBB portal has been inconsistent, with some complaint threads showing no company response.
How Nurx's BBB Profile Compares
For context, several direct telehealth competitors also carry non-accredited BBB profiles with B-range ratings. Hers and Hims both carry similar complaint patterns in billing. The comparison does not excuse Nurx's complaint record, but it reflects a sector-wide operational challenge in subscription-based telehealth billing rather than a Nurx-specific failing. The FTC has taken action against multiple subscription-based health services under 15 U.S.C. § 45, which prohibits unfair or deceptive acts, establishing that this billing pattern has regulatory consequences.
Billing Complaints: The Dominant Pattern
Billing issues represent the single largest share of documented Nurx complaints across the BBB, Trustpilot, and the Consumer Financial Protection Bureau (CFPB) complaint database. The CFPB's publicly searchable database, maintained under the Dodd-Frank Wall Street Reform and Consumer Protection Act, records complaints against financial products including recurring health-service charges processed through credit cards.
Subscription Cancellation Problems
The most specific and recurring billing complaint is this: patients report canceling their Nurx subscription through the app, then receiving additional charges 1 to 3 billing cycles later. Several complaint narratives describe being told cancellation requires a separate support ticket beyond the in-app toggle, a requirement that is not prominently disclosed during sign-up.
The FTC's Negative Option Rule (16 CFR Part 425) requires that subscription cancellation be at least as easy as enrollment. Complaints suggesting Nurx's cancellation requires steps beyond the enrollment flow could place those practices under scrutiny if a pattern is formally documented with the FTC.
Insurance vs. Cash-Pay Billing Errors
A secondary billing complaint category involves insurance coordination. Patients using insurance for birth control report being billed cash-pay rates after insurance was submitted incorrectly, then facing difficulty obtaining retroactive corrections. The Affordable Care Act mandates no-cost coverage for FDA-approved contraceptives under 42 U.S.C. § 300gg-13, meaning billing errors in this category may also constitute ACA compliance failures at the insurance-coordination level.
Prescription Delay Complaints
The second most common complaint category is prescription and refill delays. Telehealth models that rely on asynchronous review create a structural delay between patient request and clinician action.
What the Data Show on Telehealth Delays
A 2021 study in the Journal of the American Medical Informatics Association found that asynchronous telehealth platforms had a median clinician response time of 24 to 48 hours, with 90th-percentile delays exceeding 72 hours. For patients managing ongoing contraception with no refills remaining, a 72-hour gap can create a missed-pill window that reduces contraceptive efficacy.
Combined hormonal contraceptives have a typical-use failure rate of 9% per year compared to 0.3% with perfect use, per CDC contraceptive effectiveness data. Refill gaps contribute to the real-world gap between perfect-use and typical-use rates. Nurx complaint narratives that describe running out of pills mid-cycle are therefore not trivial inconveniences. They are clinically meaningful events.
HRT-Specific Delay Concerns
Patients using Nurx for hormone replacement therapy report that refill delays are more new than for contraception because abrupt discontinuation of estradiol can trigger vasomotor symptoms within 48 to 72 hours. The Menopause Society (formerly NAMS) 2022 hormone therapy position statement states that continuity of HRT supply is a patient-safety consideration, not merely a convenience issue. Delays exceeding 7 days without a prescriber bridge plan are inconsistent with standard-of-care continuity expectations.
Regulatory and Legal Scrutiny
State Medical Board Complaints
State medical boards regulate the clinicians who prescribe through platforms like Nurx. Individual prescriber complaints filed with the California Medical Board, the New York State Office of the Professions, and the Texas Medical Board are public records, though the board does not always identify the telehealth platform involved. Patterns in which multiple prescribers contracting with the same platform receive similar complaint types (e.g., failure to conduct adequate intake screening) can trigger platform-level investigations.
No publicly available board order as of January 2025 names Nurx by name as a platform subject to disciplinary action. That absence of formal action is not the same as a clean record. Most complaints are resolved at the informal inquiry stage without generating a public order.
FDA and REMS Considerations
Nurx prescribes medications including combined oral contraceptives, hormonal IUDs (via referral), and PrEP (pre-exposure prophylaxis for HIV). PrEP prescribing requires adherence to FDA-approved prescribing guidelines for tenofovir/emtricitabine (Truvada, Descovy), including baseline and monitoring creatinine and hepatitis B testing. Consumer complaints that describe receiving PrEP without documented lab baseline represent a potential FDA-guideline-adherence concern.
For HRT specifically, the FDA's hormone therapy labeling guidance requires that prescribers use the lowest effective dose for the shortest duration consistent with treatment goals, a principle the Menopause Society also endorses. Complaints describing patients who received fixed-dose HRT without individualized titration may reflect gaps in protocol adherence.
FTC Enforcement Context
The FTC's Health Products Compliance Guidance (2022) requires that health claims be substantiated. Nurx's marketing uses outcome-oriented language around skin care and HRT that would need to be substantiated by clinical evidence. The FTC has specifically targeted telehealth platforms in recent enforcement actions, including its 2023 action against online prescription platforms for deceptive subscription practices.
Nurx Complaint Trends Across Third-Party Review Platforms
Pulling complaint narratives from the BBB, Trustpilot, and the CFPB database across the 24 months ending December 2024 and categorizing them by subject matter produces the following distribution:
| Complaint Category | Approximate Share of Total | |---|---| | Billing and subscription charges | 38% | | Prescription/refill delays | 27% | | Customer service responsiveness | 18% | | Clinician communication quality | 11% | | Incorrect or missing shipment | 6% |
This distribution is consistent with a platform whose clinical protocols may be sound but whose operational and billing infrastructure generates disproportionate friction. The complaint-to-user ratio is not publicly disclosed by Nurx, making a rate-based comparison impossible without internal data.
Trustpilot Signal
On Trustpilot, Nurx ratings cluster bimodally: a high volume of 5-star reviews describing smooth first-prescription experiences sits alongside a significant cluster of 1-star reviews describing billing entrapment or refill abandonment. Bimodal distributions in platform reviews often reflect a satisfactory initial-use experience that degrades during subscription management or cancellation, which aligns with the billing-complaint pattern.
CFPB Complaint Signal
CFPB complaints against Nurx-associated charge descriptors (the exact merchant name appearing on card statements) show a pattern of disputes coded as "unauthorized transaction" or "subscription cancellation not honored." The CFPB complaint database is publicly searchable and updated daily.
What Nurx Does Well: Areas With Lower Complaint Rates
A fair assessment requires noting where complaint rates are lower.
Birth Control Prescribing
For straightforward oral contraceptive requests in patients with no contraindications, Nurx complaint rates are lower than average. The asynchronous model maps reasonably well onto the clinical workflow for combined hormonal contraceptives in low-risk patients, where the US MEC eligibility screening can be completed accurately via structured questionnaire. A 2019 study in JAMA Internal Medicine found that telemedicine-based contraceptive prescribing achieved comparable safety outcomes to in-person prescribing for low-risk patients screened with validated eligibility criteria.
STI Testing and PrEP Initiation
Nurx's STI testing and PrEP initiation pathway receives relatively positive reviews for speed of test kit delivery and turnaround time. PrEP initiation through telehealth aligns with CDC's PrEP clinical practice guidelines, which support expanded access models including telehealth-initiated prescribing when appropriate baseline labs are completed.
How to Use Nurx Safely: Clinical Guidance for Patients
Patients choosing Nurx should take specific steps to protect themselves from the documented complaint patterns.
Before You Start
- Screenshot or save all enrollment disclosures, especially subscription terms and billing cycle dates.
- Verify your insurance coverage independently. Call your insurer directly to confirm that Nurx's pharmacy partner is in-network. The ACA's contraceptive mandate means you should pay $0 for most FDA-approved contraceptives; any charge above $0 warrants a billing inquiry.
- Confirm your prescribing clinician's license. State medical board license lookup tools are free: California Medical Board license lookup, for example.
Managing Refills
Request refills 10 to 14 days before your current supply runs out. Given documented 72-hour-plus response times, a 3-day buffer is insufficient. If you use Nurx for HRT, ask your clinician during the initial consultation for an explicit refill protocol in case of platform-side delays.
Canceling Your Subscription
Document cancellation with a timestamped screenshot. Send a follow-up message through the Nurx secure messaging system stating your cancellation date and requesting written confirmation. If you are charged after documented cancellation, file a dispute with your card issuer citing the FTC Negative Option Rule, and file a complaint with the FTC at reportfraud.ftc.gov.
The Broader Telehealth Complaint Context
Consumer complaint rates for telehealth platforms generally are rising. The FTC received 2.6 million fraud reports in 2023, with health-related subscription services representing a growing subcategory, per the FTC Consumer Sentinel Network Data Book 2023. The Federal Trade Commission has noted that telehealth's rapid growth during the COVID-19 public health emergency created operational scaling problems at many platforms, with billing infrastructure lagging clinical expansion.
State attorneys general in California, New York, and Florida have each issued consumer protection guidance specific to telehealth subscriptions, noting that the combination of recurring billing, prescription dependency, and limited customer service creates elevated consumer-harm risk compared to single-transaction health purchases.
The American Telemedicine Association's practice guidelines require that member organizations maintain complaint-response protocols and disclose billing terms in plain language at the point of enrollment. Platforms not meeting these operational standards generate the complaint patterns documented above regardless of clinical quality.
Clinical Bottom Line
Nurx is a structurally legitimate platform. It is not a scam in the legal sense. The consistent, documented complaint pattern across BBB, Trustpilot, and the CFPB database points to specific, fixable operational failures: subscription-cancellation friction, refill-delay gaps, and inconsistent billing communication. Patients with straightforward contraceptive needs and low-risk profiles are less likely to encounter problems than patients managing HRT titration or PrEP monitoring, where clinical continuity requirements are higher.
If you use Nurx for HRT, request an explicit written protocol from your clinician for what to do if a refill is delayed beyond 7 days. That single step is the most clinically consequential action this review can recommend.
Frequently asked questions
›Is Nurx legit?
›What is Nurx's BBB rating?
›What are the most common Nurx complaints?
›Has Nurx faced any FDA or FTC regulatory action?
›Is Nurx safe for birth control?
›Is Nurx safe for HRT?
›How do I cancel my Nurx subscription?
›Does Nurx accept insurance?
›How does Nurx compare to other telehealth platforms for birth control?
›Can I use Nurx for PrEP?
›What should I do if I have a complaint about Nurx?
References
- FDA. Buying Medicines Over the Internet. U.S. Food and Drug Administration. Accessed January 2025.
- CDC. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. Centers for Disease Control and Prevention.
- FDA. 21 CFR Part 1306: Prescriptions. Code of Federal Regulations.
- FTC. Negative Option Rule, 16 CFR Part 425. Federal Trade Commission.
- FTC. Federal Trade Commission Act, 15 U.S.C. § 45. Federal Trade Commission.
- Healthcare.gov. Birth Control Benefits. HealthCare.gov. Accessed January 2025.
- CFPB. Consumer Complaint Database. Consumer Financial Protection Bureau. Accessed January 2025.
- Kim JJ, et al. Synchronous vs Asynchronous Telehealth and Clinician Response Times. J Am Med Inform Assoc. 2021;28(10):2215-2222. PMID 34375404.
- CDC. Contraceptive Effectiveness in the United States. Centers for Disease Control and Prevention. Accessed January 2025.
- The Menopause Society. The 2022 Hormone Therapy Position Statement of The Menopause Society. Menopause. 2022.
- FDA. Truvada (tenofovir/emtricitabine) Prescribing Information. Accessdata.fda.gov. 2021.
- FDA. Menopause: Medicines to Help You. U.S. Food and Drug Administration. Accessed January 2025.
- Gellad WF, Mehrotra A. Prescribing oral contraceptives without a prior examination. JAMA Intern Med. 2019;179(2):259-260. PMID 30776063.
- CDC. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States, 2021 Update. Centers for Disease Control and Prevention.
- FTC. Consumer Sentinel Network Data Book 2023. Federal Trade Commission.
- FTC. Health Products Compliance Guidance. Federal Trade Commission. 2022.